Valuation: Abbott Laboratories

Market Cap 201B 172B 161B 147B 278B 19,171B 280B 1,899B 740B 9,663B 754B 738B 31,991B P/E 2026 *
33.3x
P/E 2027 * 25.7x
Enterprise Value 225B 193B 180B 165B 311B 21,455B 314B 2,125B 829B 10,814B 844B 826B 35,802B EV / Sales 2026 *
4.47x
EV / Sales 2027 * 4.06x
Free-Float
86.16%
Yield 2026 *
2.21%
Yield 2027 * 2.36%
1 week+1.61%
Current month+5.63%
1 month+8.57%
3 months+25.55%
6 months-16.13%
Current year-16.13%
1 week 110.37
Extreme 110.37
110.37
1 month 101.66
Extreme 101.66
110.37
Current year 82.56
Extreme 82.56
131.6
1 year 82.56
Extreme 82.56
131.6
3 years 82.56
Extreme 82.56
131.6
5 years 82.56
Extreme 82.56
131.6
10 years 82.56
Extreme 82.56
131.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.61% - - 202B
-0.46%+5.22%-12.41%+11.93% 202B
-1.89%+0.60%-1.69%+12.44% 119B
+1.33%+4.97%+12.12%+83.51% 61.78B
+0.40%-5.32%+30.83%+55.98% 52.35B
-0.50%+4.22%-4.95%-31.49% 51.96B
-2.09%+0.45%+8.39%-11.71% 34.36B
+2.71%+2.18% - - 30.44B
-1.37%+0.54%+40.60%-11.04% 24.87B
+0.04%-0.90%-5.19%+24.89% 24.07B
Average +0.18%+1.45%+8.46%+16.81% 66.74B
Weighted average by Cap. +0.08%+2.83%+1.00%+18.00%

Financials

2026 *2027 *
Net sales 50.3B 43.08B 40.31B 36.85B 69.59B 4,799B 70.21B 475B 185B 2,419B 189B 185B 8,008B 54.65B 46.8B 43.79B 40.03B 75.6B 5,213B 76.27B 516B 201B 2,628B 205B 201B 8,699B
Net income 6.23B 5.34B 4.99B 4.57B 8.62B 595B 8.7B 58.9B 22.96B 300B 23.4B 22.89B 992B 7.92B 6.79B 6.35B 5.81B 10.96B 756B 11.06B 74.89B 29.19B 381B 29.75B 29.1B 1,262B
Net Debt 23.94B 20.5B 19.18B 17.54B 33.12B 2,284B 33.41B 226B 88.19B 1,151B 89.88B 87.92B 3,811B 20.96B 17.95B 16.79B 15.35B 28.99B 1,999B 29.25B 198B 77.21B 1,008B 78.68B 76.97B 3,336B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
24/08/26 USD 110.37 0.00%
21/08/26 USD 110.37 0.00%
20/08/26 USD 110.37 0.00%
19/08/26 USD 110.37 0.00%
18/08/26 USD 110.37 +1.61%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.13USD
Average target price
120.20USD
Spread / Average Target
+3.50%

Quarterly revenue - Rate of surprise